CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas - PubMed (original) (raw)
. 2005 Feb 1;65(3):828-34.
Affiliations
- PMID: 15705880
CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas
Masanobu Abe et al. Cancer Res. 2005.
Abstract
Neuroblastoma, one of the most common pediatric solid tumors, is characterized by two extreme disease courses, spontaneous regression and life-threatening progression. Here, we conducted a genome-wide search for differences in DNA methylation that distinguish between neuroblastomas of the two types. Three CpG islands (CGI) and two groups of CGIs were found to be methylated specifically in neuroblastomas with a poor prognosis. By quantitative analysis of 140 independent cases, methylation of all the five CGI (groups) was shown to be closely associated with each other, conforming to the CpG island methylator phenotype (CIMP) concept. The presence of CIMP was sensitively detected by methylation of the PCDHB CGIs and associated with significantly poor survival (hazard ratio, 22.1; 95% confidence interval, 5.3-93.4; P < 0.0001). Almost all cases with N-myc amplification (37 of 38 cases) exhibited CIMP. Even in 102 cases without N-myc amplification, the presence of CIMP (30 cases) strongly predicted poor survival (hazard ratio, 12.4; 95% confidence interval, 2.6-58.9; P = 0.002). Methylation of PCDHB CGIs, located in their gene bodies, did not suppress gene expression or induce histone modifications. However, CIMP was significantly associated with methylation of promoter CGIs of the RASSF1A and BLU tumor suppressor genes. The results showed that neuroblastomas with CIMP have a poor prognosis and suggested induction of silencing of important genes as an underlying mechanism.
Similar articles
- Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Abe M, Watanabe N, McDonell N, Takato T, Ohira M, Nakagawara A, Ushijima T. Abe M, et al. Oncology. 2008;74(1-2):50-60. doi: 10.1159/000139124. Epub 2008 Jun 11. Oncology. 2008. PMID: 18544995 - Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.
Abe M, Westermann F, Nakagawara A, Takato T, Schwab M, Ushijima T. Abe M, et al. Cancer Lett. 2007 Mar 18;247(2):253-8. doi: 10.1016/j.canlet.2006.05.001. Epub 2006 Jun 6. Cancer Lett. 2007. PMID: 16759796 - Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas.
Asada K, Abe M, Ushijima T. Asada K, et al. J Hum Genet. 2013 Jul;58(7):428-33. doi: 10.1038/jhg.2013.64. Epub 2013 Jun 6. J Hum Genet. 2013. PMID: 23739128 Review. - Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A, Matsuura K, Moriya S, Fukuba I, Yamaoka H, Fukuda E, Kamei N, Hiyama K, Sueda T, Hiyama E. Kamimatsuse A, et al. Pediatr Blood Cancer. 2009 Jul;52(7):777-83. doi: 10.1002/pbc.21977. Pediatr Blood Cancer. 2009. PMID: 19260109 - CpG island methylator phenotype (CIMP) in cancer: causes and implications.
Teodoridis JM, Hardie C, Brown R. Teodoridis JM, et al. Cancer Lett. 2008 Sep 18;268(2):177-86. doi: 10.1016/j.canlet.2008.03.022. Epub 2008 May 8. Cancer Lett. 2008. PMID: 18471961 Review.
Cited by
- Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer.
Zhu Q, Fu M, Qi J, Xu Z, Wang Y, Wang Z, Wang D, Liu J, Du R, Wei X, Wang H, Nie J, Hong B, Xu W. Zhu Q, et al. iScience. 2024 Jun 28;27(8):110413. doi: 10.1016/j.isci.2024.110413. eCollection 2024 Aug 16. iScience. 2024. PMID: 39108724 Free PMC article. - Targeting DNA Methylation Machinery in Pediatric Solid Tumors.
Cristalli C, Scotlandi K. Cristalli C, et al. Cells. 2024 Jul 18;13(14):1209. doi: 10.3390/cells13141209. Cells. 2024. PMID: 39056791 Free PMC article. Review. - Epigenetic Dysregulation in _MYCN_-Amplified Neuroblastoma.
Epp S, Chuah SM, Halasz M. Epp S, et al. Int J Mol Sci. 2023 Dec 3;24(23):17085. doi: 10.3390/ijms242317085. Int J Mol Sci. 2023. PMID: 38069407 Free PMC article. Review. - The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.
Ando K, Nakagawara A. Ando K, et al. Cells. 2023 Feb 8;12(4):544. doi: 10.3390/cells12040544. Cells. 2023. PMID: 36831211 Free PMC article. Review. - Comparative epigenomics by machine learning approach for neuroblastoma.
Sugino RP, Ohira M, Mansai SP, Kamijo T. Sugino RP, et al. BMC Genomics. 2022 Dec 27;23(1):852. doi: 10.1186/s12864-022-09061-y. BMC Genomics. 2022. PMID: 36572864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous